• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
Stock Screener·China·Healthcare·000989.SZ
Share

Jiuzhitang Co., Ltd. Stocks

CN¥ 9.29Last Updated 14.07.2026

Issuer Rating

5/7
Performance

Favourable

Risk

Low

Recommendation

Hold

Market Cap

CN¥ 1.02B

CN¥ 9.29
Key Takeaways

Risk factor

Strong & resilient to price shocks

Data is available to registered users only
Data is available to registered users only

Profitability factor

Solid dividends

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

Jiuzhitang Co., Ltd. is a Chinese pharmaceutical company specializing in the development and distribution of traditional Chinese, chemical, biological, and health-related medicinal products. Its product portfolio addresses a wide array of health concerns. For instance, cardiovascular and cerebrovascular conditions are treated with offerings like shuxuetong injections, Angong Niuhuang Wan, Danxi granules, and Gastrodia Uncaria. Gynecological issues are targeted by Guizhi Fuling pills, Buxue Shengru granules, and other hemostasis and analgesic preparations. Respiratory ailments can be managed with Schicon, while digestive disorders benefit from products such as Jiaqi Ganzian granules, Jianwei Yuyang tablets, Jienchang Ning, and Chidan yellowing products. Furthermore, the company supplies a comprehensive range of over-the-counter (OTC) medications. These non-prescription drugs support areas including qi and blood nourishment, cardiovascular and cerebrovascular health, urinary system function, pediatric care, women's health, musculoskeletal wellness, respiratory relief, dermatological conditions, nervous system support, ENT treatments, digestive aid, and even tumor-related concerns. Established in Beijing, China, in 1999, Jiuzhitang Co., Ltd. maintains its headquarters there.

Company Valuation

Fairly valued
4/7

Considering past and projected metrics, the stock is neither 'expensive' nor 'cheap' compared to its peers. Specifically, the stock is fairly valued on P/E, neutral on EV

Data is available to registered users only
Sign up to access detailed valuation

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

Trending

14.07.2026 09:30

Sam Altman "took the scam to a whole new level": Musk comments on Apple's lawsuit against OpenAI

14.07.2026 08:30

Disney's decision to abandon streaming will boost its stock by 40% — Wells Fargo

14.07.2026 07:30

Jefferies recommended buying shares of Hoka's parent company. The brand could replicate UGG's success.

14.07.2026 02:42

Prosecutors from 12 U.S. states have filed a lawsuit against the Paramount-Warner Bros. Discovery deal

14.07.2026 01:22

SK Hynix Led the Decline Among Chipmakers; Oil Prices Suffered Their Sharpest One-Day Drop Since 2020

X-channel

Buy

Sell

0 more stocks

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn

Services

  • Stock Screener
  • Guru Portfolios
  • X (Twitter)
  • LinkedIn
Oninvest© 2026